The effects of solid food in prevention of intestinal activity in Tc-99m tetrofosmin myocardial perfusion scintigraphy

Journal of Nuclear Cardiology

Volumn 10, Issue 2, 2003, Pages 161-167

  Boz, Adil ^a   Gungor, Firat ^a   Karayalçin, Binnur ^a   Yildiz, Akin ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Artifacts; Inferior wall to abdomen count ratio; Intestinal activity; Technetium 99m tetrofosmin myocardial perfusion scintigraphy

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FREQUENCY ANALYSIS; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTESTINE MOTILITY; MAJOR CLINICAL STUDY; MALE; MEAL; MILK; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION;

EID: 0037367286     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.398     Document Type: Article

References (18)

1. Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-11.
2. Higley B, Smith FW, Smith T, et al. Technetium-99m-1,2-bis [bis(2-ethoxyethyl) phosphino]ethane: biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.
3. Rehm PK, Atkins FB, Zeissman HA, et al. Frequency of extracardiac activity and its effect on Tc-99m MIBI cardiac SPET interpretation. Nucl Med Commun 1996;17:851-6.
4. Braat SH, Leclercq B, Itti R, et al. Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols. J Nucl Med 1994;35:1581-5.
5. Karayalçm B, Boz A, Güngör F. Early duodenogastric reflux in Tc-99m tetrofosmin myocardial scintigraphy: a case report. Clin Nucl Med 1998;23:844-5.
6. Kabasakal L, Collier BD, Shaker R, et al. Enterogastric bile reflux during technetium-99m-sestamibi cardiac imaging. J Nucl Med 1996;37:1285-8.
7. Wackers FJT. Myocardial perfusion imaging. In: Sandler MP, Coleman RE, Wackers FJT, et al, editors. Diagnostic nuclear medicine. Philadelphia: Williams and Wilkins; 1996. p. 443-516.
8. Boz A, Karayalçin B. Which is better for inferior wall evaluation: a full or empty stomach. J Nucl Med 1996;37:1916-7.
9. Boz A, Yildiz A, Güngör F, Karayalçin B, Erkilic M. The volume effect of the stomach on intestinal activity on same-day exercise-rest Tc-99m tetrofosmin myocardial imaging. Clin Nucl Med 2001;26:622-5.
10. Van Train KF, Areeda J, Garcia EV, et al. Quantification same-day rest-stress technetium-99m-sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494-502.
11. Cuocolo A, Soricelli A, Nicolai E, et al. Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery stenosis in previous myocardial infarction. J Nucl Med 1995;36:907-13.
12. (99m)Tc-tetrofosmin. Eur J Nucl Med 2002;29:46-52.
13. Karesh SM. Principles of radiopharmacy. In: Henkin RE, Boles MA, Karesh SM, et al, editors. Nuclear medicine. St. Louis: Mosby; 1996. p. 334-49.
14. Weinmann P, Moretti JL. Metoclopramide has no effect on abdominal activity of sestamibi in myocardial SPET. Nucl Med Commun 1999;20:623-5.
15. Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with Tc-99m sestamibi. Clin Nucl Med 1993;18:735-41.
16. van Dongen AJ, van Rijk PP. Minimizing liver, bowel and gastric activity in myocardial perfusion SPECT. J Nucl Med 2000;41: 1315-7.
17. Hassan IM, Mohammad MMJ, Constantinides C, et al. Problems of duodenogastric reflux in Tc-99m Hexa MIBI planar, tomographic and bull's eye display. Clin Nucl Med 1989;14:286-9.
18. Germano G, Chua T, Kiat H, Areeda JS, Berman DS. A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies. J Nucl Med 1994;35:356-9.